1. Barrio JR (1983) Biochemical parameters in radiopharmaceutical design. In: Heiss WD, Phelps ME (eds) Positron emission tomography of the brain. Springer, Berlin Heidelberg New York, pp 65–76
2. Budinger TF (1981) Revival of clinical nuclear medicine brain imaging. J Nucl Med 22: 1094–1096
3. Bustany P, Sargent T, Saudubray JM, Henry JF, Comar D (1981) Regional human brain uptake and protein incorporation of C-L-methionin studied in-vivo with PET. J Cereb Blood Flow Metabol 1 (Suppl 1): 17–18
4. Bustany P, Henry JF, Sargent T, Zarifian E, Cabanis E, Collard P, Comar D (1983) Local brain protein metabolism in dementia and schizophrenia: In-vivo studies with C-L-methionine and positron emission tomography. In: Heiss WD, Phelps ME (eds) Positron emission tomography of the brain. Springer, Berlin Heidelberg New York, pp 208–211
5. >Comar D, Berridge M, Maziere B, Crouzel C (1982) Radiopharmaceuticals labelled with positron-emitting radioisotopes. In: Ell PJ, Holman BL (eds) Computed emission tomography. Oxford University Press, Oxford New York Toronto, pp 42–90